High Throughput Process Development Market by Product & Service (Instrument, Software and Service), Molecule Type (Monoclonal Antibodies, Recombinant Insulin), Process (Upstream, Downstream), End User (Contract Manufacturing Organization) – Forecast to 2021

◆상품코드 : MAM-BT5157
◆발행일 : 7-Apr-2017
◆페이지수 : 150
◆보고서 형식 : PDF / 영문
◆납품 방식 : Email
◆조사대상 지역 : Global
◆산업분야 : Healthcare & Bio
◆발행회사(조사회사) : MarketsandMarkets
◆판매회사 : H&I글로벌리서치(주)
◆판매가격 옵션
Single User¥638,450 -> 환산 ₩6,384,500견적의뢰/구매/질문FORM
Multi User (Five User)¥751,450 -> 환산 ₩7,514,500견적의뢰/구매/질문FORM
Corporate License¥920,950 -> 환산 ₩9,209,500견적의뢰/구매/질문FORM
※지불하실 금액은 상기금액이며, 세금 및 배송료는 없습니다.
※지불은 선불결제 방식이며, 신용카드결제 또는 계좌입금(국내/해외)이 선택가능합니다.
※구매의사를 FORM기입 또는 E메일로 연락주시면 담당자가 회신 드리겠습니다.
※배송은 입금 확인 후, E메일로 납품드리며, 일반적으로 당일~2일정도 소요됩니다.
※가격옵션 설명 : (Single User : 귀사내에서 1명만 사용가능 / Five User, Multi User : 귀사내에서 5명까지 사용가능 / Site License, Corporate License : 동일국내에서 인원제한없이 사용가능 / Global Site License, Enterprise License : 지역상관없이 인원제한없이 사용/공유 가능한 라이센스). 자세한 설명은 이용안내 페이지를 참고하세요.


[조사보고서 개요]

The global high throughput process development market is expected to reach USD 19.78 Billion in 2021 from USD 9.91 Billion in 2016, at a CAGR of 14.8% from 2016 to 2021.
Growth in the market is mainly driven by the increasing R&D spending, technological advancements in process development, growth in the biopharmaceutical industry, and growing pressure to lower the cost of manufacturing. However, factors such as the high cost of technology and equipment in this market and lack of adequate infrastructural facilities are restraining the growth of this market to a certain extent.

The market is segmented on the basis of molecule type, end user, process, product and service, and region. Based on molecule type, the market is segmented into monoclonal antibodies, vaccine, recombinant insulin, human growth hormones, and others (interferons and interleukins). The monoclonal antibodies segment accounted for the largest share of the global market in 2016. The large share of this segment is attributed to the increasing adoption of targeted immunotherapy and the increasing number of U.S. FDA-cleared therapeutic monoclonal antibodies.

Based on process, the market is segmented into upstream and downstream. The downstream processing segment accounted for the largest share of the global high throughput process development market in 2016. This is attributed to the increasing demand for purified biosimilars and the increased adoption of disposable technologies in the manufacturing process of biosimilars. However, high labor costs and high costs associated with purification materials in downstream processing are likely to restrain the growth of this market during the forecast period.

Geographically, North America (comprising the U.S. and Canada) accounted for the largest share of the global high throughput process development market in 2016. Factors such as increase in R&D spending by pharmaceutical and biopharmaceutical companies, growing demand for technical tools for improving the production quality of biological materials, collective pressure towards lowering the cost of manufacturing biological materials, rising demand for reducing product development timelines, and the presence of major players in this region are driving the growth of the North American market. Compared to the mature markets, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. Factors such as increasing R&D spending, growing trend of outsourcing, growing public-private partnerships, and increasing government funding for infrastructural development are driving the growth of the Asia-Pacific market.

Major players operating in the high throughput process development market include Danaher Corporation (U.S.), GE Healthcare (U.S.), Agilent Technologies (U.S.), Merck Millipore (Germany), and Thermo Fisher Scientific (U.S.).

[조사보고서 목차]

1 Introduction (Page No. – 13)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 16)
2.1 Research Approach
2.1.1 Key Data From Secondary Sources
2.1.2 Key Data From Primary Sources
2.1.2.1 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study

3 Executive Summary (Page No. – 24)

4 Premium Insights (Page No. – 29)
4.1 High Throughput Process Development Market Snapshot: 2016 vs 2021
4.2 High Throughput Process Development Market, By Product and Region
4.3 High Throughput Process Development Market, By Molecule Type, 2016 vs 2021 (USD Billion)
4.4 High Throughput Process Development Market, By Process, 2016 vs 2021 (USD Billion)
4.5 High Throughput Process Development Market, By End User, 2016 vs 2021 (USD Billion)
4.6 High Throughput Process Development Market, By Region

5 Market Overview (Page No. – 33)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing R&D Spending
5.2.1.2 Technological Advancements in Process Development
5.2.1.3 Growth in the Biopharmaceutical Industry
5.2.1.4 Growing Pressure to Lower the Cost of Manufacturing
5.2.2 Restraints
5.2.2.1 High Cost of Advanced High Throughput Process Development Technologies and Lack of Adequate Infrastructural Facilities
5.2.3 Current Trends
5.2.3.1 Outsourcing to Contract Manufacturing Organizations
5.2.3.2 Adoption of Quality By Design(QBD) Principles

6 High Throughput Process Development Market, By Product & Service (Page No. – 40)
6.1 Introduction
6.2 Consumables & Reagents
6.3 Instruments
6.4 Software & Services

7 High Throughput Process Development Market, By End User (Page No. – 47)
7.1 Introduction
7.2 Biopharmaceutical Manufacturers
7.3 Contract Manufacturing Organizations

8 High Throughput Process Development Market, By Molecule Type (Page No. – 53)
8.1 Introduction
8.2 Monoclonal Antibodies
8.3 Vaccines
8.4 Recombinant Insulin
8.5 Human Growth Hormones
8.6 Other Molecules

9 High Throughput Process Development Market, By Process (Page No. – 64)
9.1 Introduction
9.2 Downstream Processing
9.3 Upstream Processing

10 High Throughput Process Development Market, By Region (Page No. – 71)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 Rest of Europe (RoE)
10.4 Asia-Pacific
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 97)
11.1 Overview
11.2 Comparative Assessment of Key Market Players
11.3 Compettitive Situation and Trends
11.3.1 Product Launches
11.3.2 Agreements and Partnerships
11.3.3 Acquisitions
11.3.4 Expansions
11.3.5 Other Strategies

12 Company Profiles (Page No. – 105)
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 Introduction
12.2 Danaher Corporation
12.3 GE Healthcare
12.4 Thermo Fisher Scientific Inc.
12.5 Merck Millipore
12.6 Agilent Technologies, Inc.
12.7 Bio-Rad Laboratories, Inc.
12.8 Eppendorf AG
12.9 Perkinelmer, Inc.
12.10 Sartorius Stedim Biotech
12.11 Tecan Group Ltd.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 136)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.5 Introducing RT: Real-Time Market Intelligence
13.6 Available Customizations
13.7 Related Reports
13.8 Author Details

List of Tables (85 Tables)

Table 1 High Throughput Process Development Market Size, By Product & Service, 2014–2021 (USD Million)
Table 2 High Throughput Process Development Consumables and Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 3 North America: High Throughput Process Development Consumables and Reagents Market Size, By Country, 2014–2021 (USD Million)
Table 4 Europe: High Throughput Process Development Consumables and Reagents Market Size, By Country, 2014–2021 (USD Million)
Table 5 High Throughput Process Development Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 6 North America: High Throughput Process Development Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 7 Europe: High Throughput Process Development Instruments Market Size, By Country, 2014–2021 (USD Million)
Table 8 High Throughput Process Development Software and Services Market Size, By Region, 2014–2021 (USD Million)
Table 9 North America: High Throughput Process Development Software and Services Market Size, By Country, 2014–2021 (USD Million)
Table 10 Europe: High Throughput Process Development Software and Services Market Size, By Country, 2014–2021 (USD Million)
Table 11 Global Market Size, By End User, 2014-2021 (USD Million)
Table 12 Market Size for Biopharmaceutical Manufacturers, By Region, 2014-2021 (USD Million)
Table 13 North America: Market Size for Biopharmaceutical Manufacturers, By Country, 2014–2021 (USD Million)
Table 14 Europe: Market Size for Biopharmaceutical Manufacturers, By Country, 2014–2021 (USD Million)
Table 15 Market Size for Contract Manufacturing Organizations, By Region, 2014-2021 (USD Million)
Table 16 North America: Market Size for Contract Manufacturing Organizations, By Country, 2014–2021 (USD Million)
Table 17 Europe: Market Size for Contract Manufacturing Organizations, By Country, 2014–2021 (USD Million)
Table 18 Market Size, By Molecule Type, 2014–2021 (USD Million)
Table 19 Therapeutic Monoclonal Antibodies Approved By Fda in 2016
Table 20 Market Size for Monoclonal Antibodies, By Region, 2014–2021 (USD Million)
Table 21 North America: Market Size for Monoclonal Antibodies, By Country, 2014–2021 (USD Million)
Table 22 Europe: Market Size for Monoclonal Antibodies, By Country, 2014–2021 (USD Million)
Table 23 Market Size for Vaccines, By Region, 2014–2021 (USD Million)
Table 24 North America: Market Size for Vaccines, By Country, 2014–2021 (USD Million)
Table 25 Europe: Market Size for Vaccines, By Country, 2014–2021 (USD Million)
Table 26 Market Size for Recombinant Insulin, By Region, 2014–2021 (USD Million)
Table 27 North America: Market Size for Recombinant Insulin, By Country, 2014–2021 (USD Million)
Table 28 Europe: Market Size for Recombinant Insulin, By Country, 2014–2021 (USD Million)
Table 29 Market Size for Human Growth Hormones, By Region, 2014–2021 (USD Million)
Table 30 North America: Market Size for Human Growth Hormones, By Country, 2014–2021 (USD Million)
Table 31 Europe: Market Size for Human Growth Hormones, By Country, 2014–2021 (USD Million)
Table 32 Market Size for Other Molecules, By Region, 2014-2021 (USD Million)
Table 33 North America: Market Size for Other Molecules, By Country, 2014–2021 (USD Million)
Table 34 Europe: Market Size for Other Molecules, By Country, 2014–2021 (USD Million)
Table 35 Market Size, By Process, 2014–2021 (USD Million)
Table 36 Market Size for Downstream Processing, By Region, 2014–2021 (USD Million)
Table 37 North America: Market Size for Downstream Processing, By Country, 2014–2021 (USD Million)
Table 38 Europe: Market Size for Downstream Processing, By Country, 2014–2021 (USD Million)
Table 39 Market Size for Upstream Processing, By Region, 2014–2021 (USD Million)
Table 40 North America: Market Size for Upstream Processing, By Country, 2014–2021 (USD Million)
Table 41 Europe: Market Size for Upstream Processing, By Country, 2014–2021 (USD Million)
Table 42 Market Size, By Region, 2014–2021 (USD Million)
Table 43 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 44 North America: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 45 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 46 North America: Market Size, By Molecule Type, 2014–2021 (USD Million)
Table 47 North America: Market Size, By Process, 2014–2021 (USD Million)
Table 48 U.S.: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 49 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 50 U.S.: Market Size, By Molecule Type, 2014–2021 (USD Million)
Table 51 U.S.: Market Size, By Process, 2014–2021 (USD Million)
Table 52 Canada: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 53 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 54 Canada: Market Size, By Molecule Type, 2014–2021 (USD Million)
Table 55 Canada: Market Size, By Process, 2014–2021 (USD Million)
Table 56 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 57 Europe: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 58 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 59 Europe: Market Size, By Molecule Type, 2014–2021 (USD Million)
Table 60 Europe: Market Size, By Process, 2014–2021 (USD Million)
Table 61 Germany: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 62 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 63 Germany: Market Size, By Molecule Type, 2014–2021 (USD Million)
Table 64 Germany: Market Size, By Process, 2014–2021 (USD Million)
Table 65 U.K.: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 66 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 67 U.K.: Market Size, By Molecule Type, 2014–2021 (USD Million)
Table 68 U.K.: Market Size, By Process, 2014–2021 (USD Million)
Table 69 RoE: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 70 RoE: Market Size, By End User, 2014–2021 (USD Million)
Table 71 RoE: Market Size, By Molecule Type, 2014–2021 (USD Million)
Table 72 RoE: Market Size, By Process, 2014–2021 (USD Million)
Table 73 Asia-Pacific: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 74 Asia-Pacific: Market Size, By End User, 2014–2021 (USD Million)
Table 75 Asia-Pacific: Market Size, By Molecule Type, 2014–2021 (USD Million)
Table 76 Asia-Pacific: Market Size, By Process, 2014–2021 (USD Million)
Table 77 RoW: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 78 RoW: Market Size, By End User, 2014–2021 (USD Million)
Table 79 RoW: Market Size, By Molecule Type, 2014–2021 (USD Million)
Table 80 RoW: Market Size, By Process, 2014–2021 (USD Million)
Table 81 Product Launches, 2014–2016
Table 82 Agreements and Partnerships, 2014–2016
Table 83 Acquisitions, 2014–2016
Table 84 Expansions, 2014–2016
Table 85 Other Strategies, 2014–2016



List of Figures (38 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market: Top-Down Approach
Figure 4 Market: Bottom-Up Approach
Figure 5 Market Data Triangulation Methodology
Figure 6 Global Market, By Molecule Type, 2016 vs 2021
Figure 7 Global Market, By End User, 2016 vs 2021
Figure 8 Global Market, By Process, 2016 vs 2021
Figure 9 Global Market, By Product and Service, 2016 vs 2021
Figure 10 Geographical Snapshot of the Market
Figure 11 Increasing Demand for Biopharmaceuticals is an Important Growth Driver
Figure 12 Consumables and Reagents Accounted for the Largest Market Share in 2016
Figure 13 Monoclonal Antibodies Segment Dominated the Market, By Molecule Type, in 2016
Figure 14 Downstream Processing Segment Dominated the Market in 2016
Figure 15 Biopharmaceutical Manufacturers Dominated the End-User Market in 2016
Figure 16 Asia-Pacific to Grow at the Highest Rate During the Forecast Period
Figure 17 High-Throughput Process Development Market: Drivers and Restraints
Figure 18 Pharmaceutical R&D Expenditure, By Region/Country, 2000 vs 2010 vs 2014
Figure 19 Consumables and Reagents Segment to Dominate the Market During the Forecast Period
Figure 20 Biopharmaceutical Manufacturers to Form the Largest End-User Segment in the Market
Figure 21 Monoclonal Antibodies Commanded the Largest Share of the Global Market in 2016
Figure 22 Downstream Processing Commanded the Largest Share of the Global Market in 2016
Figure 23 Market Size, By Region, 2016 vs 2021 (USD Million)
Figure 24 North America: Market Snapshot
Figure 25 Asia-Pacific: Market Snapshot
Figure 26 Companies Majorly Pursued the Strategy of Product Launches to Enhance Their Market Presence
Figure 27 Battle for Market Share: Product Launches—Key Growth Strategy Adopted By Market Players
Figure 28 Geographic Revenue Mix of the Prominent Players in the High Throughput Process Development Market
Figure 29 Danaher Corporation: Company Snapshot (2015)
Figure 30 GE Healthcare: Company Snapshot (2015)
Figure 31 Thermo Fisher Scientific Inc.: Company Snapshot (2015)
Figure 32 Merck Millipore: Company Snapshot (2015)
Figure 33 Agilent Technologies, Inc.: Company Snapshot (2016)
Figure 34 Bio-Rad Laboratories, Inc.: Company Snapshot (2015)
Figure 35 Eppendorf AG: Company Snapshot (2015)
Figure 36 Perkinelmer, Inc.: Company Snapshot (2015)
Figure 37 Sartorius Stedim Biotech: Company Snapshot (2015)
Figure 38 Tecan Group Ltd.: Company Snapshot (2015)

[보고서에 포함된 내용]
세계시장규모, 세그멘트별 시장규모, 시장동향, 시장예측, 관련 기업정보 등

[면책사항]
http://www.globalresearch.kr/disclaimer

★조사보고서 [High Throughput Process Development Market by Product & Service (Instrument, Software and Service), Molecule Type (Monoclonal Antibodies, Recombinant Insulin), Process (Upstream, Downstream), End User (Contract Manufacturing Organization) – Forecast to 2021]에 관해서 E메일 문의 연락
◆H&I글로벌리서치의 고객기업(예)◆